• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Natco Pharma Limited — Board Meeting, 12-02-2026: Outcome of Board Meeting

    12-02-2026 | 02:40 pm

    Natco Pharma announced Q3FY26 consolidated revenue of ₹705.4 Cr & net profit of ₹151.3 Cr. The Board declared a ₹1.50 interim dividend and re-appointed key directors. Amit Parekh was appointed new CFO, and plans for a Chile subsidiary with up to $300,000 investment were approved.

    No comments yet. Be the first to comment!

    All announcements from Natco Pharma Limited